Clinova Limited has announced that they have received a Certificate of grant of patent by the Intellectual Property Office for O.R.S®. Clinova’s innovative O.R.S soluble tablets are a scientifically balanced formula of glucose, salts and electrolytes.
The patent will provide Clinova and their O.R.S® brand with long term protection and security in key markets and will also offer Clinova lower tax implications of 6% as part of the UK patent box.
For further information about the patent, please contact our information department on firstname.lastname@example.orgTags: IPO, ORS
This post was written by david